Jason Katner

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat

Chad J. Swanson, Kenneth W. Perry, Susanne Koch-Krueger et al. · Neuropharmacology · 2006 · 215 citations

Medicine, Neuroscience, Pharmacology +16

Ethanol and negative feedback regulation of mesolimbic dopamine release in rats

R. Kohl, Jason Katner, Eyassu Chernet et al. · Psychopharmacology · 1998 · 123 citations

Life Sciences, Neurobiology, Neuroscience +14

N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes

Matthew Fell, Jeffrey M. Witkin, Julie F. Falcone et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 99 citations

Medicine, Neuroscience, Pharmacology +17

Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas

Kenneth W. Perry, Julie F. Falcone, Matthew Fell et al. · Neuropharmacology · 2008 · 83 citations

Life Sciences, Neuroscience, Pharmacology +9

A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models

Linda M. Rorick‐Kehn, Roberto Ciccocioppo, Conrad J. Wong et al. · Alcoholism Clinical and Experimental Research · 2016 · 62 citations · Full text

Medicine, Neuroscience, Pharmacology +15